[HTML][HTML] A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

…, E Muñiz-Díaz, I Casas-Flecha… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …

[PDF][PDF] Lactancia materna y protección contra las infecciones respiratorias en los primeros meses de vida

…, A Delgado Iribarren, I Casas Flecha - Pediatría Atención …, 2011 - SciELO Espana
BUENO CAMPANA, MM et al. Lactancia materna y protección contra las infecciones respiratorias
en los primeros meses de vida. Rev Pediatr Aten Primaria [online]. 2011, vol. 13, n. 50, …

Convalescent plasma for COVID-19: a multicenter, randomized clinical trial

…, E Muniz-Diaz, JM Domingo-Morera, I Casas-Flecha… - MedRxiv, 2020 - medrxiv.org
Background Passive immunotherapy with convalescent plasma (CP) is a potential treatment
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …

[HTML][HTML] Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19

…, J Miguel Cisneros, J Pachón, I Casas-Flecha… - Scientific Reports, 2022 - nature.com
The main objective was to evaluate the viability of the SARS-CoV-2 viral particles excreted
in stools. In addition, we aimed to identify clinical factors associated with the detection of …

Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain

…, C Blanco, F Pozo, IC Flecha… - The Pediatric …, 2007 - journals.lww.com
Background: Rhinovirus is a recognized cause of common cold, proven to cause asthma
exacerbations in children. In Spain, no description exists, as yet, as to the degree of burden …

Infecciones virales de vías respiratorias en los primeros seis meses de vida

…, J Valverde Cánovas, I Casas Flecha - 2008 - repisalud.isciii.es
[ES] Antecedentes: El virus respiratorio sincitial (VRS) y otros virus son causas conocidas
de hospitalización en lactantes. Menos conocido es el patrón de virus en infecciones …

Human case of swine influenza A (H1N1), Aragon, Spain, November 2008

…, P Rodrigo Val, P Sanchez Villanueva, I Casas Flecha… - 2009 - repisalud.isciii.es
… Citation style for this article: Adiego Sancho B, Omeñaca Terés M, Martínez Cuenca S,
Rodrigo Val P, Sánchez Villanueva P, Casas I, Pozo F, Pérez Breña P. Human case of …

[HTML][HTML] Granuloma annulare triggered by SARS‐CoV‐2 infection: Immunohistochemical staining

…, M García‐García, I CasasFlecha… - Dermatologic …, 2021 - ncbi.nlm.nih.gov
Dear Editor, Several skin lesions have been associated with COVID-19, some of them
classically related to other microbiological agents. 1 Recently, positivity for SARS-CoV/SARS-CoV-…

Epidemiology of the 2009 influenza pandemic in spain. the spanish influenza surveillance system

…, FP Sánchez, JL Moreno, IC Flecha… - … y Microbiología Clínica, 2012 - Elsevier
In accordance with European Centre for Disease Prevention and Control recommendations,
the Spanish Influenza Surveillance System (SISS) maintained its activity during the summer …

Biodefensa: un nuevo desafío para la microbiología y la salud pública

MJ Buitrago Serna, I Casas Flecha… - … . microbiol. clín.(Ed …, 2007 - pesquisa.bvsalud.org
El bioterrorismo y el uso potencial de armas biológicas se ha convertido en una preocupación
importante de los gobiernos y autoridades competentes. Como ejemplo, el envío de …